Stock Events

Stock Events

Hikma Pharmaceuticals 

€31.2
450
+€0+0% Friday 07:55

Statistics

Day High
31.2
Day Low
31.2
52W High
32
52W Low
30.6
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
4.64%
Dividend
1.45

Upcoming

18
AUG
Dividend Ex
Estimated
 
29
SEP
Dividend Payment
Estimated
 
19
MAR 27
Dividend Ex
Estimated
 
11
MAY 27
Dividend Payment
Estimated
 
18
AUG 27
Dividend Ex
Estimated
 

Dividends

4.64%Dividend Yield
May 26
€0.83
Sep 25
€0.62
May 25
€0.89
Sep 24
€0.58
May 24
€0.87
10Y Growth
9.86%
5Y Growth
10.54%
3Y Growth
8.3%
1Y Growth
-3.85%

Earnings

6AugExpected
Q4 2025
Next
0.91
1.24
1.58
1.91
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow H5PA.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap41.6B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, directly competing with Hikma in the generics and branded drugs markets.
Novartis
NVS
Mkt Cap278.64B
Novartis is a large multinational pharmaceutical company with a strong presence in generic drugs through its Sandoz division, making it a direct competitor to Hikma.
Pfizer
PFE
Mkt Cap146.36B
Pfizer is a global pharmaceutical corporation with a broad portfolio that includes generic drugs, competing with Hikma in various therapeutic areas.
Abbvie
ABBV
Mkt Cap356.49B
AbbVie, known for its significant research-based pharmaceuticals, competes with Hikma in the specialty pharmaceuticals market, particularly in areas like immunology and oncology.
Johnson & Johnson
JNJ
Mkt Cap532.77B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes with Hikma in the development and marketing of pharmaceuticals for various therapeutic areas.
Merck
MRK
Mkt Cap275.09B
Merck & Co. is a global healthcare company that competes with Hikma in the development, manufacturing, and marketing of pharmaceuticals and vaccines.
GSK
GSK
Mkt Cap101.2B
GlaxoSmithKline is a global healthcare company that competes with Hikma in the pharmaceutical and vaccines sectors, with a broad portfolio of products.
Sanofi
SNY
Mkt Cap103.76B
Sanofi is a global pharmaceutical company that competes with Hikma in the areas of generics, specialty care, and vaccines.
Astrazeneca
AZN
Mkt Cap283.47B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Hikma in the development and commercialization of prescription medicines across multiple therapy areas.

About

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom.
Show more...
CEO
H.E Said Samih Taleb Darwazah
Employees
9400
Country
United Kingdom
ISIN
US4312881091
WKN
000A1JTM3

Listings

MX
MX
HIKN.MX
STU
DE
H5P.STU
MU
DE
H5P.MU
F
DE
H5PA.F

0 Comments

Share your thoughts

FAQ

What is Hikma Pharmaceuticals stock price today?▼
The current price of H5PA.F is €31.2 EUR — it has increased by +0% in the past 24 hours. Watch Hikma Pharmaceuticals stock price performance more closely on the chart.
What is Hikma Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Hikma Pharmaceuticals stocks are traded under the ticker H5PA.F.
When is the next Hikma Pharmaceuticals earnings date?▼
Hikma Pharmaceuticals is going to release the next earnings report on August 06, 2026.
Does Hikma Pharmaceuticals pay dividends?▼
Yes, H5PA.F dividends are paid semi-annual. The last dividend per share was 0.83 EUR. As of today, Dividend Yield (FWD)% is 4.64%.
How many employees does Hikma Pharmaceuticals have?▼
As of May 17, 2026, the company has 9,400 employees.
In which sector is Hikma Pharmaceuticals located?▼
Hikma Pharmaceuticals operates in the Health & Wellness sector.
When did Hikma Pharmaceuticals complete a stock split?▼
Hikma Pharmaceuticals has not had any recent stock splits.
Where is Hikma Pharmaceuticals headquartered?▼
Hikma Pharmaceuticals is headquartered in London, United Kingdom.